![]() |
|
|
Forward to a colleague |
||
Access Full Stories Two new techniques have been developed that could signal the end of PCR (polymerase chain reaction) amplification for sequencing applications and dramatically increase the efficiency of sample preparation... Read Wyeth ups the ante with new proteomics method Researchers from Wyeth Research's Biological Technologies division have described how the use of a titania-affinity enrichment step can aid in the discovery of post-translational protein modifications... Read Boehringer hopes cash injection will turbocharge diabetes and obesity programme Boehringer Ingelheim has witnessed Vitae Pharmaceuticals attack the same diabetes and obesity target as itself, only faster, and has decided to splash out for a piece of the action... Read Industry news in brief - week 42 LabTechnologist.com brings you its periodic round up of industry news, with developments at Affymetrix Labs, AlphaSniffer, Corning, DNAPrint Genomics, Illumina and Rules-Based Medicine... Read Ventana to help develop pathway for companion diagnostics The Critical Path Institute (C-Path) and diagnostics expert Ventana Medical Systems are collaborating to develop a standard submission route for targeted therapies and companion diagnostics... Read |
||||||||||||||||||
All News Headlines for: October | September | August |
||||||||||||||||||
Manufacturing Variations in Polysorbate Batches Lot to lot variances in a series of Polysorbate preparations was easily and clearly differentiated and identified by utilizing charged aerosol detection (CAD), a new universal detectorfor HPLC... Click Here | ||||||||||||||||||
|
Related Industry News Pfizer gets chatty with docs online Pfizer has gone where no pharmaceutical company has gone before - a social networking website... Read Roche results up on oncology portfolio Roche announced its third quarter financials today, with its portfolio of oncology products such as Herceptin (trastuzumab) and Avastin (bevacizumab) performing strongly, and helping off-set the massive 60 per... Read Improved infrastructure key to cheaper drugs Improving the technology infrastructure of drug development could save the industry hundreds of millions of dollars, according to a new US government study, with the ultimate winners being patients... Read Billionaire 'raider' circles as Biogen put up for sale Biogen Idec has announced it is seeking a buyer for the company and has already received several expressions of interest - including a reputed $23bn (€16.2bn) bid from billionaire corporate raider Carl Icahn... Read
|
||||||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@LabTechnologist.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||